European Journal of Clinical Pharmacology

, Volume 43, Issue 5, pp 563–565 | Cite as

Correlations between theophylline concentrations in plasma, erythrocytes and cantharides-induced blister fluid and peak expiratory flow in asthma patients

  • F. Philip-Joet
  • B. Bruguerolle
  • M. Reynaud
  • A. Arnaud
Short Communications

Summary

Theophylline levels in plasma, erythrocytes and cantharides-induced blister fluid (BF) have been correlated with peak expiratory flow (PEF) in asthmatic patients. Nine asthmatic men received an IV infusion of 240 mg theophylline at a constant rate for 30 min.

The theophylline concentrations in erythrocytes and blister fluid were 37 % and 78 % of those in plasma. There was not a strong correlation between erythrocyte or blister fluid penetration and the clinical effect of theophylline.

Key words

Theophylline, Asthma blister fluid, erythrocytes, free levels, peak expiratory flow, pharmacokinetics 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blaive B, Lapalus P, Lemoigne F, Bugnas B (1981) Théophylline: paramétres pharmacocinétiques individuals. Application à la détermination d'une posologie individuelle efficace. Clin Resp Physiol 17: 413–416Google Scholar
  2. Bruguerolle B (1986) Erythrocyte binding of theophylline determined by the EMIT system. Clin Chem 32: 896–897Google Scholar
  3. Kalager T, Digranes A, Salveson A, Bergan T, Korting HC (1985) Pharmacokinetics of brodimoprim in serum and skin blister fluid. Chemother 31: 405–409Google Scholar
  4. Korting HC, Schäfer-Korting M, Haag R, Mutschler E (1984) Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea. Int J Clin Pharmacol Ther Toxicol 22: 218–220Google Scholar
  5. Korting HC, Belz G, Brauer J, Alken R, Mutschler E (1987) Digoxin concentrations in serum and cantharides blister fluid: correlations with cardiac response. Clin Pharmacol Ther 42: 613–620Google Scholar
  6. Lebel M, Gregoire S, Caron M, Bergeron M (1985) Difference in blister fluid penetration after single and multiple doses of ceftriaxone. Antimicrob Agent Chemother 28: 123–127Google Scholar
  7. Lockley MR, Wise R, Dent J (1984) The pharmacokinetics and tissue penetration of ofloxacin. J Antimicrobial Chemother 14: 647–652Google Scholar
  8. Meneely GR, Renzetti AD, Steele JD, Wyatt JP, Harris HW (1962) Definitions and classification of chronic bronchitis asthma and pulmonary emphysema. Am Rev Resp Dis 85: 762–768Google Scholar
  9. Netter R, Bannwarth B, Royer-Morrot MJ (1989) Recent findings on the pharmacokinetics of non steroidal antiinflammatory drugs in synovial fluid. Clin Pharmacokinet 17: 145–162Google Scholar
  10. Schäfer-Korting M, Korting HC, Hiemstra S, Mutschler E (1982) Does cantharides blister fluid provide access to the peripheral compartment? Eur J Clin Pharmacol 23: 327–330Google Scholar
  11. Schäfer-Korting M, Korting HC, Mutschler E (1985) Human plasma and skin blister fluid levels of griseofulvin following a single oral dose. Eur J Clin Pharmacol 29: 109–113Google Scholar
  12. Tight R, White C (1980) Serum and subcutaneous chamber fluid dynamics of penicillins after single large parenteral doses. Antimicrob Agent Chemother 17: 229–234Google Scholar
  13. Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, Washington, pp 75–119Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • F. Philip-Joet
    • 1
  • B. Bruguerolle
    • 2
  • M. Reynaud
    • 1
  • A. Arnaud
    • 1
  1. 1.Pneumoallergology DepartmentCHU NordMarseille Cedex 15France
  2. 2.Clinical and Experimental Pharmacology LaboratorySchool of MedicineMarseilleFrance

Personalised recommendations